What is glucophage used for
Searched over 200M research papers
Summary
7 papers analyzed
These studies suggest Glucophage (metformin) is used to improve glycemic control in type 2 diabetes, promote diabetic wound healing, and potentially prevent or delay the onset of diabetes in high-risk patients.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Uses of Glucophage (Metformin)
Introduction to Glucophage (Metformin)
Glucophage, commonly known as metformin, is a widely used oral medication primarily prescribed for the management of type 2 diabetes. It belongs to the biguanide class of drugs and is known for its efficacy in controlling blood glucose levels.
Primary Use: Management of Type 2 Diabetes
Glycemic Control in Type 2 Diabetes
Metformin is the first-line treatment for type 2 diabetes, particularly for patients who have not achieved adequate glycemic control through diet and exercise alone. It works by decreasing hepatic glucose production, increasing insulin sensitivity, and enhancing peripheral glucose uptake and utilization. Extended-release formulations of metformin, such as Glucophage XR, have been shown to be effective in maintaining glycemic control with a favorable safety profile.
Prevention of Type 2 Diabetes in High-Risk Individuals
Metformin is also used to prevent or delay the onset of type 2 diabetes in individuals with prediabetes. This includes patients with fasting plasma glucose levels between 100-125 mg/dL, 2-hour post-load glucose levels of 140-199 mg/dL, or an A1C of 5.7-6.4%. It is particularly recommended for those under 60 years old, with a BMI over 35 kg/m², or a history of gestational diabetes.
Secondary Uses: Diabetic Wound Healing
Enhancement of Diabetic Wound Healing
Recent studies have explored the use of metformin in promoting the healing of diabetic wounds. Nanofibrous glucophage-loaded collagen/PLGA scaffold membranes have been developed to provide sustained release of metformin, significantly enhancing wound healing and increasing collagen content in diabetic rats. This is achieved through the down-regulation of matrix metalloproteinase 9, which is crucial for collagen degradation.
Combination Therapy
Synergy with Other Antidiabetic Agents
Metformin is often used in combination with other antidiabetic medications to improve glycemic control. For instance, the combination of sitagliptin (Januvia) and metformin (Glucophage) has been shown to effectively lower blood glucose levels in patients with type 2 diabetes, indicating a synergistic effect between the two drugs.
Conclusion
Glucophage (metformin) is a versatile medication primarily used for the management of type 2 diabetes and the prevention of the disease in high-risk individuals. Its role extends beyond glycemic control to include the promotion of diabetic wound healing and potential benefits in combination therapy with other antidiabetic agents. The broad applications and efficacy of metformin make it a cornerstone in the treatment and management of diabetes.
Sources and full results
Most relevant research papers on this topic
